Who
David Dalvey
Director
Company insider
Files Form 4 as: Director, Celcuity; Director, Navarre Corp /mn/.
In numbers
- Trades disclosed
- 42
- Buys
- 0
- Sells
- 10
- Bought
- $0
- Sold
- $18.5M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 1 Apr 2010
- Last trade
- 5 Jun 2026
- Last filed
- 9 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 9 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —1,530 at $0.00 | filing |
| 5 Jun 2026filed 9 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —1,530 at $0.00 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $3.5M25,000 at $140.68 | filing |
| 4 May 2026filed 6 May 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $3.5M25,000 at $140.68 | filing |
| 27 Jan 2026filed 29 Jan 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $2.4M20,000 at $120.03 | filing |
| 27 Jan 2026filed 29 Jan 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $2.4M20,000 at $120.03 | filing |
| 21 Nov 2025filed 24 Nov 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $1.5M15,000 at $100.00 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $139K3,137 at $44.36 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $188K4,163 at $45.24 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $93K2,025 at $46.05 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $2.5M57,044 at $43.30 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $993K22,377 at $44.36 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $744K16,438 at $45.29 | filing |
| 28 Jul 2025filed 30 Jul 2025 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $191K4,141 at $46.05 | filing |
| 19 May 2025filed 21 May 2025 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,048 at $0.00 | filing |
| 4 Jun 2024filed 6 Jun 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,153 at $0.00 | filing |
| 15 Dec 2023filed 18 Dec 2023 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $43K2,940 at $14.57 | filing |
| 14 Dec 2023filed 18 Dec 2023 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $74K5,000 at $14.75 | filing |
| 13 Dec 2023filed 14 Dec 2023 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $73K5,000 at $14.50 | filing |
| 12 Dec 2023filed 14 Dec 2023 | CELC CelcuityBiotechnology | SEC FORM 4 Sold | $30K2,060 at $14.61 | filing |
News
No headline names them, or the companies they trade most, lately.